D
3.92
-0.27 (-6.33%)
| Previous Close | 4.19 |
| Open | 4.13 |
| Volume | 464,567 |
| Avg. Volume (3M) | 692,118 |
| Market Cap | 449,224,160 |
| Price / Earnings (Forward) | 17.83 |
| Price / Sales | 1.74 |
| Price / Book | 1.24 |
| 52 Weeks Range | |
| Earnings Date | 11 Aug 2025 |
| Profit Margin | -206.05% |
| Operating Margin (TTM) | -11.81% |
| Diluted EPS (TTM) | -4.41 |
| Quarterly Revenue Growth (YOY) | -6.80% |
| Total Debt/Equity (MRQ) | 41.43% |
| Current Ratio (MRQ) | 1.75 |
| Operating Cash Flow (TTM) | 67.67 M |
| Levered Free Cash Flow (TTM) | 68.25 M |
| Return on Assets (TTM) | -0.43% |
| Return on Equity (TTM) | -89.99% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bullish | Mixed |
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | Definitive Healthcare Corp. | Bullish | Mixed |
AIStockmoo Score
-0.6
| Analyst Consensus | -1.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -2.5 |
| Average | -0.63 |
|
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 9.15% |
| % Held by Institutions | 96.92% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 6.00 (Stifel, 53.06%) | Buy |
| Median | 4.70 (19.90%) | |
| Low | 3.40 (Goldman Sachs, -13.27%) | Hold |
| Average | 4.70 (19.90%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 3.71 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Stifel | 08 Aug 2025 | 6.00 (53.06%) | Buy | 3.84 |
| Goldman Sachs | 12 May 2025 | 3.40 (-13.27%) | Hold | 3.58 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Aug 2025 | Announcement | Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025 |
| 24 Jul 2025 | Announcement | Definitive Healthcare Announces Timing of Its Second Quarter 2025 Financial Results Conference Call and Webcast |
| 03 Jun 2025 | Announcement | Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |